Member Info for mulledwine

Interim Management Statement and Production Report for the three months ended 30 September 2012 Overview · Record year to date attributable gold production of 375,637 ounces, a 15.1% increase over the same period of 2011. · Attributable quarterly gold production of 126,841 ounces increased by 5.9% compared to 3Q11 due to the contribution from the new Noche Buena mine. · Year to date attributable silver production, including the Silverstream (3.1Moz.) decreased by 3.6% when compared to the same period in 2011 as a result of the anticipated decline in silver grades at the Fresnillo mine. However, silver production continues to improve quarter on quarter. · Quarterly silver production of 10.3 million ounces, including the Silverstream, a 2.6% increase over the same period of 2011. · Resources were increased at each of our seven operating mines with reserves notably increased at Noche Buena and Saucito. Audited figures will be released alongside our preliminary results on early March 2013. · On track to achieve annual silver production target of 41Moz and 460,000 ounces of gold.

http://www.investegate.co.uk/Article.aspx?id=201210150700076514O

Commenting on the results, Stephan Shakespeare, Chief Executive, said: "I am pleased to report that we have achieved the objectives we set at the beginning of the year. We have continued to develop and invest in our growing portfolio of data products and services and increase revenue from these. This has helped to drive the momentum in our custom and data businesses, particularly in the US and UK. The focus on profitability under the new management in Germany is delivering planned margin improvements. The launch of the French business has gone well and regionally generated business is growing strongly in the Middle East offsetting the expected end to the large historic contract in Iraq. Innovation remains a key differentiator and the initial customer feedback from recent launches has been very encouraging. YouGov is well placed to continue to outperform the research market both in terms of sales growth and our reputation for new product development: this, combined with our strong balance sheet, underpins our continued investment in the business and the decision to commence the payment of a dividend. Current trading is in line with the Board's expectations although the macro-economic environment especially in Europe remains uncertain"`

Operational Highlights · YouGov continues to increase market share with strong growth in its major markets and in data products and services · Like-for-like revenue increased by 9%2 · Maiden dividend of 0.5p per share to be paid · US increased revenues by 21% to £19.2m (8% organic growth rate); UK by 15% · BrandIndex global revenue increased by 39% to £4.4m · Good progress made in turning around the German business; profit doubled to £0.6m on revenue of £9.4m (2011: £11.3m) · Middle East regionally generated business grew by 19% partly offsetting the £2m decline from the expected ending of the long-term contract in Iraq · Nordic revenue up 6% - ahead of market · New French operation started well: panel has already reached 75,000 · Social Media Analysis (SoMA) product launched · Strong balance sheet with net cash balances of £7.2m (2011: £9.4m) after making £2.5m of earn-out payments for previous acquisitions · Current trading in line with the Board's expectations

http://www.investegate.co.uk/Article.aspx?id=201210150700076520O

John McArthur, CEO of Tracsis plc commented: "Steve and Andy have both been instrumental in our success in the past few years and their breadth of knowledge in the rail and infrastructure industries will continue to be of significant value to the Group. Both will continue to play a fundamental role in the Group's development over the coming years and we are very pleased to welcome them to our Management Board."

Strengthened Management Board Tracsis, a developer and consolidator of resource optimisation, data capture and reporting technologies to the transport industries is pleased to announce that it has strengthened the Management Board of the Group with the promotion of Andy Whawell and Steve Brown. Steve has worked with Tracsis since joining via the acquisition of RWA Rail in 2008. Having a Masters' degree in Rail Systems Engineering and previously having held a position with AEA Technology Rail (now DeltaRail) he is a seasoned rail professional with extensive experience in the industry. Steve will assume the position of Business Development Director. Andy was Operations Director of MPEC Technology at the time of its acquisition by Tracsis in May 2011 and has continued to work as Managing Director of this division. Having joined the rail industry in 1996, Andy worked for Balfour Beatty in maintenance and projects before joining their signalling technologies division in 2001. His responsibilities in this role were to develop business for and deliver new products into the signalling industry. Andy Whawell is now Director of Infrastructure Services.

http://www.investegate.co.uk/Article.aspx?id=201210150700126324O

Simon Fox commented: "It has very quickly been confirmed to me that Trinity Mirror is a business with great brands, passionate and dedicated people and significant unrealised potential. What has become clear in my first few weeks is that realising this potential requires a flatter and more efficient management structure that connects strategic decision making more closely with the journalistic heart of the business. I believe the changes we are making today will create One Trinity Mirror with a unique portfolio of national and regional brands and the best structure from which to develop our longer term strategic direction. I will provide a strategic update in early 2013."

CONT These changes allow a flatter, more efficient management structure to be adopted. As a consequence of this new management structure, Georgina Harvey, Managing Director - Regionals and Nick Fullagar, Director of Corporate Communications will be leaving the business. They have both made an important and valued contribution to the Group for which the Board is enormously grateful. The Group is also announcing its intention to close Happli, the recently launched daily deals business. It is considered that the business is unlikely to reach sufficient scale to become profitable in the near term. We will now enter into a period of consultation with staff working in the business. Trading remains in line with the Board's expectations. The IMS will be published on 8th November 2012 as planned.

One Trinity Mirror - Changes to Management Structure Trinity Mirror plc (the "Group") today announces a change in the management structure of the Group to create a more efficient model from which to develop our longer term strategic direction as "One Trinity Mirror". The Nationals and Regionals divisions will be unified under one management structure thereby ensuring that editorial, advertising and support functions can operate as effectively as possible across all of the Group's print and digital publishing operations. This will enable an accelerated rollout of digital products across our portfolio to drive revenues. The consolidated publishing operations will be managed by Mark Hollinshead, who is today appointed to the newly created position of Chief Operating Officer and as an Executive Director of Trinity Mirror plc. Digital product development and the specialist digital businesses (Recruitment, Property and Digital Marketing Services) as well as the Group's contract printing operations will now be separately managed and report directly into the CEO.

http://www.investegate.co.uk/Article.aspx?id=201210150700116506O

Peter Grant, Chief Executive Officer of SkyePharma, commented: "The Group's cash generative potential has been substantially boosted by five major product approvals and launches during 2012, with EXPAREL launched in the U.S; approvals and launches of Paxil CR and Requip Once-a-day in Japan; approval of RAYOS in the U.S; and the first approvals and launches of flutiform in Europe. On top of this success we have renegotiated the Group's debt to better align repayment obligations with this enhanced cash generative potential. Overall these achievements have been transformational for the Group. They have validated the Group's expertise in the complex field of respiratory development as well as our ability to improve some of the world's most successful products using our innovative oral and inhalation drug delivery capabilities. We approach the future with confidence as flutiform is launched across Europe and we generate value from our partnered and pipeline assets."

Financial position On 30 June 2012, the Group had £11.0 million of cash. As anticipated, despite the receipt of milestones following the launch of flutiform® in Germany and the UK, the Group will continue to use cash in the second half of the year, due to half those milestones being paid to Paul Capital and the continuing investment in working capital to support the launch of flutiform®. The implementation of Bond Proposals and amendment to the Facility has significantly reduced short-term liquidity demands on the Group and better aligned repayment obligations with the Group's cash generative potential.

Trading The Board's expectations for pre-exceptional operating profit for 2012 remain unchanged. Some contract development work has been delayed into 2013 but the effect of this is expected to be offset by lower costs. Revenue and pre-exceptional profits will benefit from the €8.0 million (£6.3 million) milestones following the launch of flutiform® in Germany and the UK. Net profit will be affected by exceptional charges and additional finance costs related to the Bond Proposals and CRC Amendment as described more fully below.

Further national marketing authorisations are anticipated shortly. In some countries, negotiations are required with national pricing and reimbursement authorities before the product can be made commercially available. Mundipharma aims to continue to launch as soon as possible through its network of independent associated companies once national approvals are granted and where relevant, reimbursement confirmed. According to IMS1, the preventative asthma/COPD market sizes in 2011 were estimated at £5.3 billion in Europe, £1.5 billion in Japan and £0.3 billion in Mexico, Central and South America, with four-year compound annual growth rates of 4.9 per cent., 11.5 per cent. and 16.5 per cent. respectively. The asthma segments where flutiform® will compete, are estimated to be over half these total markets, which comprise anti-leukotrienes, ICS, ICS/LABAs, LAMAs and PDE-4 inhibitors.

SKYEPHARMA PLC - INTERIM MANAGEMENT STATEMENT LONDON, UK, 15 October, 2012 - SkyePharma PLC (LSE: SKP) today publishes its Interim Management Statement for the period 1 July 2012 to 14 October 2012 and provides an update on key events since the half-year results announcement issued on 23 August 2012. Pipeline and product updates flutiform® - Europe In September 2012, flutiform® was launched in Germany and the UK and, in early October 2012, the Group received related launch milestones totalling €8.0 million (£6.3 million) from its development, marketing and distribution partner, Mundipharma International Corporation Limited ("Mundipharma"). These milestones will be included in revenues and operating profit for the year, but half of the cash received has been paid out as a mandatory prepayment of the Paul Capital Note. As announced on 3 July 2012, the European Commission adopted a decision in favour of granting marketing authorisations for flutiform®, which covers the 21 member states in the decentralised procedure. Marketing authorisations have so far been granted in 10 countries, with flutiform® launched in Germany, UK, and the Netherlands and national marketing authorisations granted in Austria, Cyprus, Denmark, Iceland, Norway, the Slovak Republic and Sweden. On 8 October 2012, the Scottish Medicines Consortium accepted flutiform® for use in NHS Scotland for appropriate asthma patients.

http://www.investegate.co.uk/Article.aspx?id=201210150700066487O

Standard Life expects to boost its UK business by two million customers over the next three years on the back of regulatory changes coming into force this month. Paul Matthews, chief executive of the firm’s UK and Europe division, said the company has “never been in a better position” due to a £600m investment in its systems to prepare for changes under the Retail Distribution Review (RDR) and pensions auto-
enrolment. He said: “We have four million customers today. With what is happening with pension reform and auto-enrolment, I can see us moving to six million in the next two to three years.” Tomorrow, the insurance giant will “go live” with the range of services it has developed ahead of changes to the long-term savings and investment industry being ushered in by the RDR, The Scotsman on Sunday says.

BAE Systems plans to splurge the proceeds of a Saudi arms deal on a share buyback to head off an investor rebellion. Invesco, the City fund manager that holds a 13.4% stake, is pushing directors to return cash after the defence group’s £28bn merger with EADS collapsed last week. The cash dispute, however, predates the EADS talks. Neil Woodford, Invesco’s top fund manager, is understood to have written in blunt terms to Dick Olver, the chairman of BAE, in May last year. The letter, a copy of which has been seen by The Sunday Times, upbraids the company for considering takeovers rather than share buybacks, a common tool for returning money to shareholders. It makes clear Woodford will consider all options, including a push to replace the board. New management could embark on a rapid sell-off to return cash to investors, resulting in a much smaller company.